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Original ArticleAdipocyte integrin-linked kinase plays a key role
in the development of diet-induced adipose
insulin resistance in male miceAimée R. Bugler-Lamb 1, Annie Hasib 1, Xiong Weng 1, Chandani K. Hennayake 1, Chenshi Lin 1,
Rory J. McCrimmon 1, Roland H. Stimson 2, Michael L.J. Ashford 1, David H. Wasserman 3, Li Kang 1,*ABSTRACT
Objective: Increased deposition of the extracellular matrix (ECM) in adipose tissue (AT) during obesity contributes to insulin resistance. The
integrin receptors transmit changes in the extracellular environment causing corresponding intracellular adaptations. Integrin-linked kinase (ILK),
an adaptor protein, is a central hub for intracellular signaling of integrins. This study determined the role of ILK in adipose function and insulin
resistance.
Methods: The pathogenic role of ILK in obesity and insulin resistance was studied in human adipose tissue and adipocyte-specific ILK-deficient
mice (ILKlox/loxAdCre). ILKlox/loxAdCre mice together with wild-type littermates (ILKlox/lox) were fed a chow diet or 60% high-fat (HF) diet for 16
weeks. In vivo insulin sensitivity was determined by hyperinsulinemic-euglycemic clamps.
Results: AT ILK expression was increased by HF diet feeding in mice and increased in visceral fat of morbidly obese humans. The HF-fed ILKlox/
loxAdCre mice displayed reduced fat mass and improved glucose tolerance relative to the HF-fed ILKlox/lox mice. During a hyperinsulinemic-
euglycemic clamp, the HF-fed ILKlox/loxAdCre mice exhibited partially improved insulin resistance in AT. Lipolysis was suppressed to a greater
extent by insulin and glucose uptake in brown AT (BAT) increased. Increased inhibition of lipolysis may have been attributed to increased
vascularization in white AT, while increased glucose uptake in BAT was associated with increased Akt phosphorylation and P38/JNK dephos-
phorylation. Notably, AT insulin sensitivity in lean mice was not affected by ILK deletion. Moreover, reduced fat mass in the HF-fed ILKlox/loxAdCre
mice may have been attributed to decreased free fatty acid uptake into adipocytes via the downregulation of CD36 gene expression. Consistent
with the results in the mice, knockdown and knockout of ILK in 3T3-L1 cells decreased lipid accumulation and CD36 gene expression during
adipogenesis.
Conclusions: These data show that adipocyte ILK is important for regulating HF diet-mediated insulin resistance in AT in a manner consistent
with AT function.
 2021 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Keywords Adipose tissue; Extracellular matrix; Insulin clamp; Insulin resistance; Integrin-linked kinase1. INTRODUCTION
Obesity is known to be a risk factor for developing insulin resistance, a
hallmark of type 2 diabetes [1,2]. In adipose tissue, obesity-associated
insulin resistance correlates with increased deposition of collagens
within the extracellular matrix (ECM) [3]. Of note, obese insulin-
resistant subjects display increased collagen deposition in their adi-
pose tissue compared to obese insulin-sensitive subjects with a similar
body mass index [4], suggesting that adipose tissue ECM remodeling
plays an important role in the pathogenesis of insulin resistance in-
dependent of obesity. It is currently unknown, however, how remod-
eling the ECM within adipose tissue affects the pathophysiology of
obesity and insulin resistance.1Division of Systems Medicine, School of Medicine, University of Dundee, Dundee, Sc
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www.molecularmetabolism.comThe ECM is important for maintaining a suitable environment for
proliferation, survival, migration, and differentiation of cells by regu-
lating growth hormones, receptors, and pH outside the cells [5].
Through substrate-adhesion molecules, the ECM regulates intracel-
lular signaling [6,7], with the main substrate adhesion molecules being
integrins [8]. Integrins are a family of >20 heterodimers that makes
interpreting the deletion of any one subunit difficult. One of the main
adaptor proteins that link integrins to intracellular signaling is integrin-
linked kinase (ILK), which together with PINCH and Parvin forms the
IPP complex [9] and binds to the b subunit of integrins [10,11]. ILK is
highly conserved and widely expressed throughout the body and
carries out multiple functions, one of which is the organization of the
actin cytoskeleton. It has been shown that whole-body ILK-deficientotland, UK 2Center for Cardiovascular Science, University of Edinburgh, Edinburgh,
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Abbreviations
AT adipose tissue
AUC area under the curve
BAT brown adipose tissue
CLAMS comprehensive lab animal monitoring system
2[14C]DG 2-[14C]deoxyglucose
ECM extracellular matrix




IPGTT intraperitoneal glucose tolerance test
NEFA non-esterified fatty acid
Ra glucose appearance rate
Rd glucose disappearance rate
Rg metabolic index for tissue glucose uptake
RER respiratory exchange ratio
RBC red blood cells
WAT white adipose tissue
Original Articlemice die at the embryotic, peri-implantation stage indicating a vital role
of ILK in development [12]. However, recent studies using conditional
ILK knockout mice suggest genetic deletion in the kidneys prevents
angiotensin II-induced renal inflammation [13]. Moreover, tissue-
specific deletion of ILK in skeletal muscle or liver ameliorated high-
fat (HF) diet-induced insulin resistance in C57BL/6 mice in the
respective tissues [14,15].
Adipose tissue is an endocrine organ that plays important roles in
regulating inflammation and metabolism. In addition to their role in fat
storage [16], adipocytes express and secrete adipokines, cytokines,
and hormones such as leptin and adiponectin, which affect appetite,
thermogenesis, glucose metabolism, fatty acid oxidation, and insulin
sensitivity [17,18]. Despite the central role of ILK in the adaptation to a
changing extracellular environment, its role in adipose tissue during
the challenge of obesity is unknown. Using adipocyte-specific ILK-
deficient mice, we aimed to understand the role of ILK in adipose tissue
in diet-induced obesity and insulin resistance.
2. MATERIALS AND METHODS
2.1. Human tissue sample collection and preparation
Paired human subcutaneous and visceral adipose tissue samples were
obtained from subjects undergoing elective abdominal surgery at the
Royal Infirmary of Edinburgh. Local ethical approval was obtained and
informed consent was obtained from each subject. The samples were
immediately frozen at 80 C until analysis. Tissue samples were
lysed using lysis buffer supplemented with 92 mg/ml of sucrose, 0.1%
beta-mercaptoethanol, 1 mM of sodium vanadate, 1 mM of benza-
midine, 0.1 M of PMSF at a pH of 7.4. The tissues were then ho-
mogenized and the protein concentration was measured using
Bradford reagent (#B6916; Sigma).
2.2. Mouse model
The generation of ILK-floxed mice was previously described in detail
[12], where the ILK gene was flanked by loxP sequences on both sides
of exon 2. To generate C57BL/6 adipocyte-specific ILK-deficient mice
(ILKlox/loxAdCre), the ILK-floxed mice were crossed with transgenic
mice expressing Cre recombinase under the control of adiponectin
promoter (#010803; Jackson Laboratory). The ILKlox/loxAdCre mice2
 2021 The Authors. Published by Elsevier Gwere confirmed by genotyping for positive adiponectin Cre and ho-
mozygous for ILK-floxed genes. The control mice used in these ex-
periments were littermates without the expression of adiponectin Cre
(ILKlox/lox). The mice were fed either a chow diet (D/811004; DBM) or a
60% high-fat (HF) diet (824054; SDS) for 16 weeks starting at 6 weeks
of age. All of the mice were housed in a temperature (22  1 C) and
humidity-controlled room with a 12-h light/dark cycle. The mice had
free access to food and water. Only male mice were used in this study
due to their high susceptibility to a robust insulin-resistant phenotype
after HF feeding. All the animal procedures complied with the ARRIVE
guidelines and were approved by the UK Home Office and the Animal
Care and Use committee of the University of Dundee.
2.3. Comprehensive lab animal monitoring system (CLAMS)
The mice at 20 weeks of age were housed in a CLAMS (Columbus
Instruments) under ambient temperatures (22  1 C) for 72 h to
monitor their food intake, water intake, respiratory exchange ratio
(RER), energy expenditure, and ambulatory activity. Light cycle, room
temperature, and access to food and water were maintained. Body
weight and composition were measured before and after the
experiment.
2.4. Hyperinsulinemic-euglycemic clamp
Five days prior to the hyperinsulinemic-euglycemic clamp (ICv), the
mice underwent surgery for vascular cannulations in both the jugular
vein (for infusing glucose, insulin, and red blood cells (RBC)) and the
carotid artery (for blood sampling) [19]. The mice were fasted for 5 h
prior to ICv, and [3-3H]glucose was infused to measure glucose flux
rates [14]. Insulin was infused at 4 mU/kg/min throughout the ICv. The
blood glucose was clamped at 6 mmol/L using a glucose infusion rate
that varied in accordance with the arterial blood glucose levels
measured every 10 min. Washed RBCs were infused at a constant rate,
which was calculated to equal the RBCs removed during the ICv. Blood
samples were taken every 10 min between 80 and 120 min to assess
glucose flux rates. At 120 min, 481 kBq of 2-[14C]deoxyglucose (2[14C]
DG) was administered as a bolus through the jugular vein to measure
the glucose uptake in individual tissues. Blood samples were taken
between 120-155 min to determine the radioactivity of 2[14C]DG after
which the mice were sacrificed and their tissues excised.
2.5. ICv plasma and tissue sample processing and glucose flux
rate determination
The radioactivity of [3-3H]glucose and [14C]2DG was measured in
plasma and [14C]2DG-phosphate was measured in the tissue samples
by liquid scintillation counting as previously described [20]. Whole-
body glucose appearance (Ra) and disappearance (Rd) were deter-
mined using non-steady-state equations for isotope dilution [21].
Endogenous glucose appearance (EndoRa) was determined by sub-
tracting the glucose infusion rate from Ra. The metabolic index for
tissue glucose uptake (Rg) was determined as previously described
[22].
Non-steady-state calculation of glucose flux




Rd ¼ Ra  Vd :dA
dT
Ra and Rd: glucose appearance and disappearance rates (mg/kg/
min), I: tracer infusion rate (dpm/min), Vd: volume distribution of
glucose, A: concentration of glucose (mg/dL), SA: specific activity of
glucose (dpm/mg), and T: time (min).
Tissue-specific glucose uptake (Rg) calculationMOLECULAR METABOLISM 49 (2021) 101197
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Rg ¼ ½
14C 2DGP in tissue
AUC plasma ½14C 2DG :average glucose concentration
[14C]-2DGP: 14C-2-deoxyglucose phosphate; [14C]2DG: 2-
deoxyglucose, and AUC: area under the curve.
Plasma insulin concentrations were measured by an Ultra-Sensitive
Rat Insulin ELISA kit (#90060; Crystal Chem). Plasma non-esterified
fatty acid (NEFA) levels were measured using a WAKO Diagnostics
assay (#434-91795, #436-91995, and #4270-77000).
2.6. Immunoblotting
Mouse adipose tissue samples including epididymal, inguinal sub-
cutaneous, and interscapular brown fat depots were homogenized in
buffer containing 50 mM of Tris, 1 mM of EDTA, 1 mM of EGTA, 10%
glycerol, 1% Triton x 100, 1 mM of DTT, 1 mM of PMSF, 1  HALT
protease inhibitor (#78430; Sigma), 50 mM of NaF, and 5 mM of
NaPPi at a pH of 7.4 using 0.5 mm zirconium oxide beads (ZROB05;
NextAdvance), centrifuged, and the supernatant was collected. The
protein concentration was measured using a Pierce BCA Protein
Assay kit (#23227; Thermo Fisher Scientific). Protein samples
(20 mg) were run on a 10% SDS-page gel and transferred to nitro-
cellulose membranes (GE10600003; Sigma). The membranes were
stained using Ponceau (P7170; Sigma) to normalize the samples. The
following antibodies (Cell Signaling Technology) were used to detect
proteins of interest: ILK (#3862), AKT (#9272), pAKT (#9271), SAPK/
JNK (#9252), pSAPK/JNK (#9251), P38 (#9212), and pP38 (#9211) at
a 1:1000 dilution.
2.7. Immunohistochemistry
Immunohistochemistry was performed on paraffin-embedded adipose
tissue sections (5 mm) using the Dundee Tayside Biorepository Tissue
Bank. The antibodies used were F4/80 (#MCA497R; AbD Serotec) and
CD31 (#NBP1-49805; Novus Biologicals). Hematoxylin and eosin
staining was used to quantify the cell size and number. Picro-Sirius
Red staining was performed using Direct Red 80 (#365548; Sigma)
and Picric acid (#P6744; Sigma). Images were captured using camera
mounted on an AxioVision microscope (Zeiss Axioscope, Germany).
The quantification was performed using Fiji and ImageJ. Cells were
individually counted and measured for cell size and number. F4/80 and
Sirius Red staining were quantified by the integrated intensity. CD31
was quantified by counting the positive structures.
2.8. Real-time PCR
RNA was extracted from the tissues using an RNeasy Mini kit (74104;
Qiagen) and reversed transcribed into cDNA using Superscript II
10000U (18064014; Invitrogen). Quantitative real-time PCR was car-
ried out using the following TaqMan probes from Applied Biosystems:
IL-6 (Mm00446190_m1), TNF-a (Mm00443260_g1), IL-10 (Mm00
439614_m1), IL-1b (Mm00434228_m1), PPARy (Mm00440904_m1),
LPL (Mm00434764_m1), FASN (Mm00662319_m1), CD36 (Mm0043
2403_m1), UCP-1 (Mm01244861_m1), PGC-1a (Mm01208835_m1),
CEBPa (Mm00514283_s1), HIF1a (Mm00468869_m1), GLUT4
(Mm01245502_m1), 18S (Hs99999901_s1), and b2M (Mm0043776
2_m1). All the data were normalized to the 18S or b2M gene
expression and analyzed using the 2-DDCT method.
2.9. Liver triglycerides
Liver triglycerides were measured in w100 mg of tissue by colori-
metric reactions using GPO (glycerol phosphate oxidase) triglyceride
reagent (#T7532-500; Pointe Scientific).MOLECULAR METABOLISM 49 (2021) 101197  2021 The Authors. Published by Elsevier GmbH. This is
www.molecularmetabolism.com2.10. Intraperitoneal glucose tolerance test (IPGTT)
The mice were weighed, individually housed, and fasted for 5 h prior to
IPGTT. The baseline glucose level (t ¼ 0) was taken for each mouse
through tail vein sampling. The mice were injected intraperitoneally
with 2 g/kg of 50% glucose and glucose levels measured over a 2-h
period.
2.11. Flow cytometry
The epididymal fat and spleen were harvested from the mice and
washed in cold sterile PBS to remove blood contamination. Cells were
isolated as described by Orr et al., 2013 [23] and stained with APC a-
mouse CD11b (#101211; BioLegend) and APC/Cy7 a-mouse F4/80
(#123117; BioLegend) for macrophages and PerCP/Cy5.5 a-mouse
GR-1 (#108427; BioLegend) for neutrophils at a 1:200 dilution. DAPI
staining (#D3571; Invitrogen) was used to quantify the live cell
numbers.
2.12. Lipoprotein lipase activity
Lipoprotein lipase activity was determined by an Lipoprotein Lipase
Activity Assay kit (Fluorometric) (ab204721; Abcam) in tissue lysates of
the epididymal adipose tissue of the mice following the manufacturer’s
instructions.
2.13. Knockdown and knockout of ILK in 3T3-L1 cells
The 3T3-L1 cells were maintained in 10% FBS media (DMEM sup-
plemented with 4.5 g/L of glucose, 1 mM of sodium pyruvate, 2 mM of
glutamine, 20 mM of HEPES, 50 mg/ml of Pen/Strep, and 50 ml of
FBS).
2.13.1. sgRNA design and cloning
The BROAD Institute web portal was used to generate top sgRNA hits.
The top five hits were used to create sgRNA oligos (forward and
reverse). The oligos were duplexed and cloned into digested PX459
plasmid (1 ug of plasmid with 1 ul of the restriction enzyme BbsI
(#R0539S; NEB)) by incubating the digested plasmid with the sgRNA
and T4 ligase (#15224041; Thermo Fisher Scientific). After bacterial
transformation, the positive clones were selected using AMP þ plates.
The positive colonies were cultured overnight at 37 C and cloned
PX459 plasmids were extracted using a QIAprep Spin Miniprep kit
(#27104; Qiagen). The plasmids were sent for sequencing with LKO.1
forward primer (U6 promoter in the PX459 plasmid) to confirm the
insertion of the sgRNA sequence.
2.13.2. Cell transfection
Undifferentiated 3T3-L1 cells were cultured as previously described
and transfected using Lipofectamine LTX with Plus Reagent (#A12621;
Thermo Fisher Scientific). In a 12-well plate, 1 mg of cloned PX459
plasmids and 2 ml of Plus Reagent were added to 50 ml of Opti-MEM
Reduced Serum Medium (#31985062; Invitrogen) in a fresh Eppendorf
tube. In a separate tube, 3 ml of Lipofectamine LTX was added to 50 ml
of Opti-MEM Reduced Serum Medium and both tubes were gently
mixed and left to incubate at room temperature for 15 min. Then 50 ml
of Lipofectamine LTX was gently added to the DNA/Plus Reagent
complex and left to incubate for a further 30 min. Once the Lipofect-
amine LTX/DNA/Plus Reagent complex formed, 100 ml was added
gently to the cells. Then, 400 ml of Opti-MEM was added to the cells
and they were incubated for 6 h at 37 C before adding 1 ml of 10%
FBS media. After an overnight incubation, the media was replaced with
10% FBS media and the cells were left to recover for 24 h at 37 C.
For cell selection, 2.5 ug/ml of puromycin was added to the cells for
48e72 h until all of the non-transfected control cells were dead. Thean open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 3
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Figure 1: ILK expression in human visceral and subcutaneous adipose tissue and murine epididymal and subcutaneous adipose tissue. (A and B) ILK protein
quantification by Western blotting in visceral and subcutaneous fat pads in humans normalized to lean individuals (n ¼ 4). (C and D) Western blotting of epididymal and
subcutaneous adipose lysates to quantify ILK expression in the chow and HF-fed ILKlox/lox and ILKlox/loxAdCre mice and normalized to the ILKlox/lox on the chow diet (n ¼ 3e6). All of
the data are represented by mean þ/ SEM with significance: *p < 0.05, **p < 0.01, ***p < 0.005, and ****p < 0.001.
Original Articlemedia was then removed, the cells washed, and 20% FBS media
(DMEM supplemented with 4.5 g/L of glucose, 1 mM of sodium py-
ruvate, 2 mM of glutamine, 20 mM of HEPES, 50 mg/ml of Pen/Strep,
and 100 ml of FBS) added to allow the cells to recover and grow to
confluency.
2.13.3. Single-cell isolation and generation of stable cell lines
Once the cells reached confluency in a T150 flask, the cells were sent
to be single-cell sorted into 96-well plates by FACS using the Core
facility at the College of Life Sciences in Dundee. Once the cells
reached confluency in the 96-well plates, they were grown up in T25
flasks, split, and analyzed by Western blotting for ILK protein
expression. A portion of the cells was lysed in cell lysis buffer (25 mM
of TriseHCL, pH 7.4, 50 mM of NaF, 0.1 mM of NaCl, 1 mM of EDTA,
5 mM of EGTA, 1% Triton-X-100, 5 mM of NaPp, 92 mg/ml of sucrose,
0.1% mercaptoethanol, 1 mM of Na3VO4, 1 mM of benzamidine, and
0.1 M of PMSF) for genomic DNA extraction. The genomic DNA
extraction was carried out following the protocol provided in a PureLink
Genomic DNA Mini kit (#K182001; Thermo Fisher Scientific). Using4
 2021 The Authors. Published by Elsevier Gprimers to amplify the targeted area of the genome (50
TCTCCGAGGTTCATTACC 30 and 50 GTTTGAAGTCAATACCGG 3’), the
PCR products were cleaned using SureClean (#BIO-37047; Meridian
Bioscience). Using a StrataClone PCR Cloning kit (#240205; Agilent),
the PCR products were cloned into the pSC-A-amp/Kan vector to
sequence individual alleles.
2.14. Oil Red O staining in the 3T3-L1 cells
A stock solution (3 mg/ml) of Oil Red O (#O0625; Sigma) was prepared
in 100% isopropanol. The working solution was composed of a ratio of
3:2 of stock solution to dH20. Once the cells fully differentiated, the
media was removed, and the cells were washed with 500 ml of PBS
and fixed in 400 ml of 4% PFA (#158127; Sigma) for 20 min at room
temperature. The cells were washed with 1 PBS twice followed by a
wash with 60% isopropanol for 5 min and left to dry. Once the cells
were completely dry, 400 ml of Oil Red O working solution was added
to each well and incubated for 10 min. The Oil Red O was then
removed, and the cells were washed four times with dH20 to remove
any excess stain. Once the water was removed and the cells were dry,MOLECULAR METABOLISM 49 (2021) 101197

























































Figure 2: Phenotypic differences between the ILKlox/lox and ILKlox/loxAdCre mice. (A) Body weights of the mice from ages 6 weekse21 weeks on the chow and HF diets
(n ¼ 10e17). (B and C) Body composition of the chow and HF-fed mice expressed as the percentage of fat and lean mass at 21 weeks of age (n ¼ 10e13). (D) Wet weights of fat
depots from the chow and HF-fed mice (n ¼ 16e30). (E and F) Hematoxylin and eosin staining in the eWAT to measure the cell diameter in the ILKlox/lox and ILKlox/loxAdCre mice
fed chow and HF diets normalized to the chow-fed ILKlox/lox mice (n ¼ 4e5). All of the data are represented by mean þ/ SEM with significance: *p < 0.05, **p < 0.01,
***p < 0.005, and ****p < 0.001.the Oil Red O was eluted using 400 ml of 100% isopropanol and left for
1 h to ensure complete elution. The isopropanol was then collected for
analysis by measuring the absorbance at 495 nm with an Envision
2104 Multilabel Plate Reader.
2.15. Statistical analysis
All the data were analyzed by unpaired Student’s t-test or two-way
ANOVA followed by Tukey’s method for multiple comparisons where
appropriate. The significance level was p < 0.05*, p < 0.01**,
p < 0.005***, and p < 0.001****. All of the data are expressed as
mean  SEM.
3. RESULTS
3.1. ILK protein expression increased in visceral adipose tissue of
morbidly obese humans and diet-induced obese mice
The protein expression of ILK was measured in visceral (vWAT)
and subcutaneous (sWAT) adipose tissue in human subjects
(anthropometric data of the human subjects are shown in
Table S1). Although there was no change in the ILK expression in
the sWAT of obese subjects, there was an increase in ILK
expression in morbidly obese individuals compared to lean in-
dividuals in the vWAT (Figure 1A/B). Consistent with our findings in
humans, ILK protein expression in epididymal fat (visceral fat
equivalent in mice) also increased in the high-fat (HF) diet-fed
obese wild-type mice (ILKlox/lox) compared with the lean ILKlox/lox
mice (Figure 1C). Interestingly, ILK protein expression was also
found to be increased in the subcutaneous fat of the HF-fed ILKlox/
lox mice relative to lean ILKlox/lox mice (Figure 1D).MOLECULAR METABOLISM 49 (2021) 101197  2021 The Authors. Published by Elsevier GmbH. This is
www.molecularmetabolism.com3.2. Adipocyte-specific deletion of ILK decreased adiposity in
obese mice without disrupting energy homeostasis
To investigate the pathophysiological role of ILK in obesity and insulin
resistance, adipocyte-specific ILK knockout mice (ILKlox/loxAdCre) were
studied. ILK protein expression in the whole adipose tissue lysates of
the ILKlox/loxAdCre mice significantly decreased compared to the wild-
type littermate ILKlox/lox mice on both HF and chow diets regardless of
fat depots (Figure 1C/D). Body weight, body composition, and wet
weights of individual tissues were not different between the ILKlox/lox
and ILKlox/loxAdCremice on the chow diet (Figure 2A/B and Fig. S1A). In
contrast, on the HF diet, there was a decrease in the percent of fat
mass and an increase in the percent of lean mass in the ILKlox/loxAdCre
mice compared to the ILKlox/lox mice despite no changes in total body
weights (Figure 2A/C). Consistent with the reduction in the percent of
fat mass, the epididymal fat (eWAT) tissue weight in the HF-fed ILKlox/
loxAdCre mice was lower compared to the HF-fed ILKlox/lox mice
(Figure 2D), while tissue weights of sWAT, brown adipose tissue (BAT),
and other non-fat tissues remained unchanged (Figure 2D and
Figure S1B). A decreased percent of fat mass in the HF-fed ILKlox/lox-
AdCre mice was associated with a decrease in the adipocyte cell size in the eWAT of the
ILKlox/loxAdCre mice compared to the ILKlox/lox mice regardless of diet
(Figure 2E/F).
Decreased adiposity is often associated with improved metabolic
regulation [24], so we next assessed energy and glucose homeostasis
in these mice. The RER, ambulatory activity, food intake, and energy
expenditure were not significantly different between the two genotypes
on either chow or HF diets (Figures S2AeH), although the mice on the
HF diet showed a decrease in their overall RER with disruption to their
circadian rhythm patterns as expected (Figure S2E).an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 5
Original Article3.3. Adipocyte-specific deletion of ILK improved glucose tolerance
and the anti-lipolytic action of insulin on lipolysis, and increased
insulin-stimulated glucose uptake in BAT of the obese mice
Glucose tolerance was impaired in the HF-fed mice compared to
the chow-fed mice, yet the HF-fed ILKlox/loxAdCre mice had
improved glucose tolerance compared to the HF-fed ILKlox/lox mice
(Figure 3A/B). We next measured the insulin sensitivity using the
hyperinsulinemic-euglycemic clamps (ICv). The arterial glucose
levels were clamped at w6 mmol/L at the steady state of the ICv
clamps (80e120 min) in all of the mice (Figure 3C). The glucose
infusion rate of the chow-fed mice was significantly higher than
the mice fed a HF diet, confirming the presence of whole-body
insulin resistance (Figure 3D). There were no significant differ-
ences in glucose infusion rates between the genotypes regardless
of diet. Plasma insulin concentrations were the same between the
genotypes at the baseline and were equivalently increased during
the ICv clamps (Figure 3E). HF diet feeding increased basal and
clamp insulin levels in both genotypes. Basal EndoRa was not
different between the genotypes or diets (Figure 3F). In the
presence of insulin, EndoRa decreased in all of the groups of mice
with greater reductions in the chow-fed mice compared to the HF-


























































































Figure 3: Glucose homeostasis and insulin sensitivity in the ILKlox/lox and ILKlox/loxAd
tests in the ILKlox/lox and ILKlox/loxAdCre mice fed either chow or HF diets represented over
euglycemic clamp in the ILKlox/lox vs ILKlox/loxAdCre mice fed either chow or HF diets. (C) Ar
steady state of the hyperinsulinemic-euglycemic clamp (n ¼ 5-9). (D) Variation in the gluc
mice (n ¼ 5-9). (E) Insulin levels in basal and clamped plasma samples in all four groups
ILKlox/loxAdCre mice on chow and HF diets (n ¼ 5-9). (G) Rd in chow and HF diet-fed ILKlox/
eWAT, sWAT, and BAT (n ¼ 4-8). I: Plasma non-esterified fatty acid (NEFA) levels at baselin
the data are represented by mean þ/ SEM with significance: *p < 0.05, **p < 0.01
6
 2021 The Authors. Published by Elsevier GEndoRa between the genotypes regardless of diet. The fold in-
crease (clamp vs baseline) in Rd was the same between the chow-
fed ILKlox/lox and ILKlox/loxAdCre mice but increased in the HF-fed
ILKlox/loxAdCre mice compared to the HF-fed ILKlox/lox mice
(Figure 3G). Consistent with the increased Rd in the HF-fed ILKlox/
loxAdCre mice, the tissue-specific glucose uptake index (Rg) in the
brown adipose tissue (BAT) was increased in the HF-fed ILKlox/
loxAdCre mice compared with the HF diet-fed ILKlox/lox mice
(Figure 3H). Although the HF diet caused a reduction in the Rg in
the eWAT and sWAT in the mice, no differences were seen in Rgs
between the genotypes on either diet (Figure 3H). The basal levels
of plasma NEFA were the same between the four groups of mice
(Figure 3I). During the ICv clamps, the NEFA levels significantly
decreased in the chow-fed mice in both genotypes. HF diet feeding
in the ILKlox/lox mice caused insulin resistance to suppress the
arterial NEFA levels. However, this resistance was diminished in
the HF-fed ILKlox/loxAdCre mice and therefore the ability of insulin
to suppress the NEFA concentration improved. As NEFA is a sur-
rogate marker of lipolysis, this finding suggested a greater sup-
pression of adipocyte lipolysis in the HF-fed ILKlox/loxAdCre mice
(Figure 3I). Collectively, these results suggested that under HF diet






























































Cre mice. (A and B) Venous glucose levels following intra-peritoneal glucose tolerance
time and by the area under the curve (AUC) (n ¼ 6-13). (CeI) The hyperinsulinemic-
terial glucose over time in all four groups maintained at 6 mmoL/l over the course of the
ose infusion rate to maintain the arterial glucose at a steady state in all four groups of
of mice (n ¼ 2-4). (F) EndoRa in basal and clamped plasma samples of the ILKlox/lox vs
lox vs ILKlox/loxAdCre mice (n ¼ 5-8). (H) Rg metabolic index for tissue glucose uptake in
e (t ¼ 0 min) and during the steady state of the clamp (80e120 min) (n ¼ 5-10). All of
, ***p < 0.005, and ****p < 0.001.
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sensitivity by stimulating glucose utilization in BAT and inhibiting
systemic lipolysis.
3.4. Improved insulin resistance in BAT of the HF-fed ILKlox/loxAdCre
mice was associated with increased Akt phosphorylation and P38/JNK
dephosphorylation
To further understand the underlying mechanisms for altered insulin
action, insulin signaling was studied in eWAT and BAT. In eWAT, the
pAKT/AKT ratio increased in the clamped tissues of the HF diet-fed
ILKlox/lox mice compared with those in basal 5-h-fasted basal tis-
sues. This increase was absent in the HF-fed ILKlox/loxAdCre mice
(Figure 4A). The mitogen-activated protein kinase (MAPK) pathway
including p38 and JNK showed no response to insulin in either ge-
notype in eWAT (Figure 4B/C). In contrast to eWAT, both pAKT and
pAKT/AKT ratios were increased in BAT of the HF-fed ILKlox/loxAdCre
mice in response to insulin stimulation. No response of pAKT and
pAKT/AKT ratios to insulin was observed in the HF-fed ILKlox/lox mice
(Figure 5A). Interestingly, unlike in eWAT, both p38 and JNK showed a
decrease in phosphorylation in clamped BAT compared to basal BAT in
the HF-fed ILKlox/loxAdCre mice. No such effect was seen in the HF-fed
ILKlox/lox mice (Figure 5B/C). The pp38/p38 and pJNK/JNK ratios also
significantly decreased in insulin-clamped tissues of the HF-fed ILKlox/
loxAdCre mice relative to basal tissues, with no such differences in the
HF-fed ILKlox/lox mice (Figure 5B/C). Furthermore, the increase in
insulin-stimulated glucose uptake in BAT of the HF-fed ILKlox/loxAdCre
mice was not associated with changes in gene expression of UCP-1 or
GLUT4 (Figure S3).
3.5. Improved anti-lipolytic response of insulin in the HF-fed
ILKlox/loxAdCre mice was associated with increased CD31
expression without changes in fibrosis or inflammation in eWAT
To further investigate how deletion of ILK decreased fat mass in eWAT
of the HF-fed mice, we examined the cell morphology and endocrine
function of eWAT. The CD31 expression decreased in the HF-fed mice
compared to the chow-fed mice in both genotypes (Figure 6A/B). The



















































Figure 4: Insulin and MAPK signaling in the eWAT of the basal and clamped HF diet-
of AKT (A), p38 (B), and JNK (C) measured by Western blotting. The ratio of phosphorylate
represented by mean þ/ SEM with significance: **p < 0.01.
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improved vascularization (Figure 6A/B). Fibrosis of the eWAT as
detected by Picro-Sirius Red staining was also increased in the HF-fed
mice compared to the chow-fed mice (Figure 6C/D). However, there
were no differences between genotypes regardless of diet (Figure 6C/
D). Similarly, HF diet feeding increased eWAT hypoxia as shown by the
increased gene expression of HIF1a in both genotypes, but no dif-
ferences were observed between genotypes regardless of diet
(Figure S4).
We next assessed the inflammatory status of the HF-fed ILK-deficient
mice. Although the gene expression of IL-10 significantly increased in
the HF-fed ILKlox/loxAdCre mice compared with the HF-fed ILKlox/lox
mice, genetic deletion of ILK in adipocytes did not affect the gene
expression of the inflammatory markers including TNF-a, IL-6, or IL-1b
(Figure 6E). Furthermore, macrophage and neutrophil infiltration in the
eWAT and spleen was measured by flow cytometry and there were no
differences observed between the genotypes (Figure S5A/B). This was
supported by the demonstration that the F4/80 expression in eWAT of
the HF-fed mice increased relative to the chow-fed mice, but there was
no difference in macrophage infiltration between the ILKlox/lox and
ILKlox/loxAdCre mice on either diet (Figure S5C/D). Taken together,
these data suggested that adipocyte-specific deletion of ILK did not
significantly change the inflammatory status of the mice after HF diet
feeding, with similar levels of immune cell infiltration, but was char-
acterized by an increased expression of IL-10 that could lead to an
increase in its secretion.
3.6. Decreased fat mass in the HF-fed ILKlox/loxAdCre mice may
have been attributed to decreased fatty acid uptake to adipocytes
with fat redistributed to the liver
Decreased fat mass in the HF-fed ILKlox/loxAdCre mice did not seem to
be attributed to changes in gene expression of PPARg, LPL, or FASN in
eWAT (Figure 6F). Likewise, LPL activity in eWAT was also the same
between the HF-fed ILKlox/loxAdCre and ILKlox/lox mice (Figure S6). In
contrast, the gene expression of CD36, fatty acid translocase, and
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Figure 5: Insulin and MAPK signaling in the BAT of the basal and clamped HF diet-fed ILKlox/lox and ILKlox/loxAdCre mice. Total protein and phosphorylated protein levels of
AKT (A), p38 (B), and JNK (C) were measured by Western blotting. The ratio of phosphorylated protein to total protein was normalized to the ILKlox/lox mice (n ¼ 5-8). All of the data
are represented by mean þ/ SEM with significance: *p < 0.05, **p < 0.01, ***p < 0.005, and ****p < 0.001.





































































































































Figure 6: Vascularization, fibrosis, and mRNA expression in the epididymal fat of the ILKlox/lox and ILKlox/loxAdCre mice. (A and B) Immunohistochemical analysis of the
vascularization in eWAT using CD31 antibody in the ILKlox/lox and ILKlox/loxAdCre mice fed chow and HF diets normalized to the chow-fed ILKlox/lox mice (n ¼ 5). (C and D) Picro-
Sirius Red staining of eWAT in the ILKlox/lox and ILKlox/loxAdCre mice fed chow and HF diets normalized to the chow-fed ILKlox/lox mice (n ¼ 4). (EeG) q-PCR analysis of gene
expression in eWAT of the HF diet-fed ILKlox/lox and ILKlox/loxAdCre mice normalized to the HF-fed ILKlox/lox (n ¼ 6-9). H: Hepatic triglyceride levels in the chow- and HF-fed ILKlox/lox
and ILKlox/loxAdCre mice normalized to the chow-fed ILKlox/lox (n ¼ 5-6). All of the data are represented by mean þ/ SEM with significance: *p < 0.05, **p < 0.01,
***p < 0.005, and ****p < 0.001.
Original Articlethe HF-fed ILKlox/loxAdCre mice compared with the HF-fed ILKlox/lox
mice, while the UCP-1 expression was not altered (Figure 6G). These
results suggested that decreased fat mass in the HF-fed ILK-deficient
mice may have been attributed to decreased fatty acid uptake into
adipocytes. To further examine where the fat went, we assessed the
liver triglyceride content and found that liver triglyceride significantly
increased in the HF-fed ILKlox/loxAdCre mice compared with the HF-fed8
 2021 The Authors. Published by Elsevier GILKlox/lox mice despite no differences between the genotypes in the
chow-fed lean mice (Figure 6H).
3.7. Reduction/deletion of ILK impaired adipogenesis in 3T3-L1
cells
To further understand the role of ILK in adipogenesis and lipid meta-
bolism in adipocytes, we generated ILK knockdown (KD) and knockoutMOLECULAR METABOLISM 49 (2021) 101197
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(KO) 3T3-L1 cells using the CRISPR-Cas9 technique (Figure S7).
Biallelic sequencing data confirmed that the transfected wild-type cells
(tWT) had identical sequences with the naïve 3T3-L1 cells, the KD cells
had mutations in one allele with a 4bp deletion, and the KO cells had
mutations on both alleles with a 5bp and 1bp deletion, respectively
(Figure S8). Upon stimulation for differentiation, lipid accumulation
measured by Oil Red O staining decreased by both KD and KO of ILK
(Figure 7A). Gene expression of adipogenic markers PPARɣ and C/
EBPa decreased in ILK KD and KO cells compared with 3T3-L1-naïve
cells (Figure 7B/C). Moreover, gene expression of CD36 also signifi-
cantly decreased in the ILK KD and KO cells compared with the tWT
controls (Figure 7D). These results suggested that ILK reduction
impaired adipogenesis in the 3T3-L1 cells.
4. DISCUSSION
ECM remodeling in adipose tissue is closely associated with devel-
oping insulin resistance in obesity [3]. Many previous studies from our
group have proven a key role of the ECM-integrin-ILK pathway in the
pathogenesis of diet-induced insulin resistance in skeletal muscle and
the liver [14,15,25,26]. In this study, we for the first time demonstrated
that ILK in adipocytes is pivotal for regulating obesity-associated
adipocyte hypertrophy and insulin resistance, but not inflammation.
In the HF diet-induced obese mice, we showed that adipocyte-specific
deletion of ILK caused smaller epididymal fat pads, decreased percent
fat mass, and partially ameliorated insulin resistance in adipose tissue
by increasing glucose uptake in BAT and enhancing the inhibitoryFigure 7: Lipid accumulation and PPARg, CEBPa, and CD36 mRNA expression in sta
generated using the CRISPR-Cas9 system. (A) Oil Red O staining of naïve 3T3-L1 wild-type
Data were normalized to the naïve 3T3-L1 wild-type cells on day 0 (prior to undifferentiatio
wild-type cells, transfected wild-type cells, ILK knockdown cells, and ILK knockout cell
undifferentiation). All of the data are represented by mean þ/ SEM with significance: *
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surrogate marker. Our studies also provide mechanistic insight in that
increased vascularization in eWAT may contribute to increased insulin
sensitivity for inhibiting lipolysis. Moreover, increased insulin-
stimulated AKT phosphorylation and P38 and JNK dephosphorylation
may contribute to increased insulin sensitivity for stimulating glucose
uptake in BAT (Figure 8A). Furthermore, it is hypothesized that
decreased fat storage in epididymal adipose tissue was due to
decreased fatty acid uptake into adipocytes through CD36 at the
expense of fatty liver (Figure 8B). While our current study demonstrated
a novel role of adipocyte ILK in adipose function and insulin resistance,
it is important to highlight the study’s limitations. Only male mice were
used in this study, which caused sex bias and constrained the
generalizability of the data in females. Despite an initial power
calculation for the sample size of the animals (n ¼ 8 with a ¼ 0.05
and power ¼ 0.8), the n number of some of the analyses (glucose
uptake) was low due to technical difficulties and therefore presents the
possibility of underpower.
Our results from adipocyte-specific deletion of ILK were consistent
with previous studies in muscle and liver, suggesting an important role
of the ECM-integrin-ILK pathway in promoting insulin resistance in
insulin-sensitive tissues of mice on a HF diet [14,15]. Likewise, upon
insulin stimulation, the presence of ILK restrained insulin signaling
among various tissues including skeletal muscle [14,15] and BAT in
the present study. ILK had no catalytic activity. Therefore, it is proposed
that the effects of ILK deletion may have been through the loss of the
ILK-PINCH-Parvin (IPP) complex. Specifically, PINCH is associated withble ILK 3T3-L1 cells. The stable ILK 3T3-L1 knockdown and knockout cell lines were
cells, transfected wild-type cells, ILK knockdown cells, and ILK knockout cells (n ¼ 7).
n). (BeD) mRNA expression of PPARg, CEBPa, and CD36 respectively in naïve 3T3-L1
s (n ¼ 5e6). Data were normalized to the naïve wild-type cells on day 0 (prior to
p < 0.05, **p < 0.01, ***p < 0.005, and ****p < 0.001.
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Figure 8: Proposed working model of how deletion of ILK in adipocytes affected insulin sensitivity and lipid accumulation. (A) The deletion of ILK in adipocytes of WAT
resulted in improved vascularization, which may contribute to improving the anti-lipolytic activity of insulin. In contrast, deletion of ILK in adipocytes of BAT increased insulin-
stimulated AKT phosphorylation and decreased p38 and JNK phosphorylation resulting in improved glucose uptake in response to insulin. (B) It is proposed that deletion of
ILK in adipocytes of WAT resulted in a decrease in CD36 gene expression and subsequent decrease in NEFA uptake into adipocytes and decreased adipose triglyceride (TG) levels.
This decrease in NEFA uptake resulted in an increase in hepatic lipid accumulation.
Original Articlethe insulin receptor signaling pathway by binding to Nck2, which in
turn interacts with insulin receptor substrate-1 (IRS-1) [27]. Graae
et al. recently demonstrated that overexpression of ADAMTS9, a
secreted metalloproteinase, decreases insulin signaling and action at
least partially through altering integrin signaling with increased ILK and
PINCH expression [28]. These results suggest that ADAMTS9 may also
be a potential link between insulin signaling and the IPP complex.
Parvin on the other hand mediates cytoskeletal dynamics by binding to
F-actin and is proposed to regulate mitochondrial energetics and
subsequent glucose metabolism through Rac1 and cofilin [29]. A po-
tential role of Parvin in the context of insulin action has not been
elucidated. It was also intriguing to see that deletion of ILK specifically
in the skeletal muscle, liver, or adipose tissue had beneficial effects on
systemic insulin resistance or glucose intolerance. While the skeletal
muscle, liver, and adipose tissue are major organs contributing to
whole-body glucose metabolism, they also secret circulating factors to
execute paracrine function and regulate insulin response in other tis-
sues. Indeed, deletion of ILK in skeletal muscle increases IL-6 gene
expression in the muscle [14] and deletion of ILK in adipocytes in-
creases IL-10 gene expression in adipose tissue. It would be inter-
esting to see whether circulating levels of these cytokines are affected
and their potential impact on insulin response.
In contrast to the emerging role of ILK in promoting obesity-associated
insulin resistance, a recent study by Hatem-Vaquero et al. showed that
global deletion of ILK in adulthood in mice caused impaired glucose
and insulin tolerance on a chow diet, with a reduction in the expression
and membrane presence of GLUT4 in the insulin-sensitive peripheral
tissues [30]. Their study suggested a critical role of ILK in maintaining
glucose homeostasis under normal physiological conditions. Our cur-
rent study, however, suggested that ILK expression specifically in
adipocytes was not required for the maintenance of glucose homeo-
stasis in the chow-fed mice, with unchanged glucose tolerance and
insulin sensitivity assessed by the insulin clamps. It was likely that a
ubiquitous deletion of ILK in the study by Hatem-Vaquero et al.
explained the discrepancies in the metabolic phenotype from our
tissue-specific ILK-deficient mice [30].
It was significant to observe the remarkable effect of ILK deletion in
reducing adipocyte size and diet-induced adiposity in themice. Although10
 2021 The Authors. Published by Elsevier Gthis did not seem to be associated with changes in the gene expression
of PPARg, FASN, or LPL, it is possible that the difference in lipid
accumulation in adipocytes was due to decreased uptake of exogenous
lipids. In adipocytes, CD36, FABPpm, Caveolin 1, and FATP1 are known
to be involved in the uptake of free fatty acids into cells [31]. Consistent
with this concept, we observed that CD36 gene expression decreased in
the HF-fed ILK-deficient mice. Few current reports support the role of
ILK in fatty acid uptake. The IPP complex is critical to cytoskeletal dy-
namics that are necessary for protein translocation. It is possible that
deletion of ILK would impair translocation of CD36 to the plasma
membrane and subsequently decrease lipid uptake in adipocytes.
Furthermore, our data in the 3T3-L1 cells showed evidence that ILK is
essential for adipogenesis and CD36 gene expression in adipocytes.
Nevertheless, decreased adipocyte hypertrophy in the adipocyte-
specific ILK-deficient mice was consistent with decreased hepatic
lipid accumulation in mice lacking ILK specific in hepatocytes [15], with
the most prominent effect in the presence of dietary lipid excess.
Decreased PGC-1a expression highlighted a potential role of ILK in
mitochondrial biogenesis and fatty acid oxidation, which could also
contribute to lipid metabolism in adipocytes. However, controversy
persists over the effects of PGC-1a on the OXPHOS system, fatty acid
transport, and fatty acid oxidation in adipocytes [32e34].
One of the most interesting findings was that increased ILK protein
expression observed in eWAT of the HF diet-fed mice mirrored the
increase in the visceral adipose tissue of morbidly obese humans. It is
important to highlight that this diet-induced increase in ILK protein was
absent in the adipose tissue of the adipocyte-specific ILK knockout
mice, indicating that this increase was likely driven by the adipocytes
themselves. The increase in ILK protein was maintained in the sWAT of
the HF-fed mice, but absent in the human sWAT. Despite many sim-
ilarities between white adipose depots from rodents and humans,
notable differences emerge related to fat deposition and function [35].
In humans, increased visceral adipose tissue is associated with insulin
resistance, dyslipidemia, and type 2 diabetes, while subcutaneous
adipose tissue is associated with preserved insulin sensitivity and
mitigates risk of metabolic disorders [36e39]. Moreover, sWAT in
humans is heterogeneous, having different physiological effects
depending on the depot location, while rodent fat depots do not harborMOLECULAR METABOLISM 49 (2021) 101197
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the complexity of human sWAT [35]. Our results that ILK increased in
vWAT but not sWAT of morbidly obese humans support the hypothesis
that ILK in visceral fat plays a pathological role in obesity-related in-
sulin resistance. The physiological and functional differences between
sWAT from humans and mice may explain the differential regulation of
ILK expression in sWAT between obese humans and mice. Moreover,
our results suggest that the ECM-integrin-ILK pathway contributes to
insulin resistance in mice, which may also apply to adipose tissue in
morbidly obese humans.
It is interesting that p38 and JNK were dephosphorylated during insulin
stimulation in BAT, but not in eWAT of the HF-fed mice. Although our
results in eWAT were consistent with previous studies showing that
insulin failed to induce any detectable activation of p38 MAPK in mouse
primary adipocytes [40], dephosphorylation of p38 by insulin in BAT
has not been shown. In 3T3-L1 adipocytes, however, activation of
MAPKs including ERK, JNK, and P38 has been shown to reduce
tyrosine phosphorylation of insulin receptor and IRS, decrease glucose
transporter GLUT4, and induce insulin resistance [41]. Moreover,
pharmacological inhibition of p38 MAPK improves insulin-stimulated
uptake of glucose and increases protein levels of GLUT4 in 3T3-L1
adipocytes [42]. These studies were consistent with our results that
increased p38/JNK dephosphorylation by insulin in the BAT of the ILK-
deficient mice was accompanied by an increase in insulin-stimulated
glucose uptake. These results were also consistent with our previous
studies in muscle-ILK-deficient mice where improved insulin-
stimulated muscle glucose uptake was accompanied by decreased
p38 activation [14]. Our results showed that the gene expression of
GLUT4 in BAT of the ILK-deficient mice was not altered. Yet it cannot
rule out that protein expression of GLUT4 and/or membrane trans-
location of GLUT4 may have been affected by ILK deletion in BAT.
Therefore, the hypothesis that in BAT, deletion of ILK decreases
phosphorylation of p38 and JNK resulting in improved insulin-
stimulated glucose uptake due to an increase in GLUT4 expression
and translocation needs further investigation.
Neural innervation of adipose tissue is critical for metabolic processes
including adipogenesis, lipolysis, and thermogenesis [43]. Vasculari-
zation and innervation are often linked and promote each other.
Indeed, CD31 expression increased in the eWAT of the HF-fed ILK-
deficient mice. It is therefore postulated that the effects of adipocyte
ILK deletion on adipose function and insulin response may be centrally
mediated through brain-adipose communication. The brain-adipose
axis can also apply to the BAT where the sympathetic drive plays a
key role in thermogenic activity. The effects of adipocyte ILK on
vascularization and innervation of both eWAT and BAT are potentially
important and remain to be studied.
5. CONCLUSION
In conclusion, our data showed that deletion of ILK in adipocytes had
beneficial effects on metabolic regulation including decreasing
adiposity and improving the anti-lipolytic action of insulin and insulin-
stimulated glucose uptake in brown adipose tissue of obese insulin-
resistant mice. In addition, our data provide mechanistic insight for
underlying mechanisms showing the role of ILK in adipocytes in
regulating the insulin and MAPK signaling pathways. Most importantly,
by showing a similar increase in ILK expression in visceral adipose
tissue of obese humans, our research is translational and may be
relevant in a clinical setting. These data together with earlier studies in
skeletal muscle and liver highly suggest that pharmacological
disruption of ILK interactions would have metabolic beneficial effects
on improving insulin sensitivity and provide promising therapeuticMOLECULAR METABOLISM 49 (2021) 101197  2021 The Authors. Published by Elsevier GmbH. This is
www.molecularmetabolism.compotential for diabetes and metabolic disorders. However, the potential
role of ILK in decreasing fatty acid uptake through CD36 needs to be
further investigated before its therapeutic consideration as it caused
fatty liver in the current study.
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